MYC and BCL2 overexpression is associated with a higher class of Memorial Sloan-Kettering Cancer Center prognostic model and poor clinical outcome in primary diffuse large B-cell lymphoma of the central nervous system.
Sehui KimSoo Jeong NamDohee KwonHannah KimEunyoung LeeTae Min KimDae Seog HeoSung Hye ParkChul Woo KimYoon Kyung JeonPublished in: BMC cancer (2016)
Evaluation of MYC and BCL2 expression may be helpful for the determination of PCNS-DLBCL prognosis.